| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.529 | 37.602 | 30.775 | 60.486 | 103.848 | 138.907 | 138.418 |
| Total Income - EUR | - | - | - | 10.529 | 37.603 | 30.776 | 60.648 | 105.826 | 139.670 | 139.522 |
| Total Expenses - EUR | - | - | - | 11 | 711 | 1.220 | 1.674 | 9.464 | 21.579 | 23.473 |
| Gross Profit/Loss - EUR | - | - | - | 10.519 | 36.892 | 29.557 | 58.973 | 96.362 | 118.091 | 116.049 |
| Net Profit/Loss - EUR | - | - | - | 10.203 | 35.764 | 28.696 | 57.195 | 93.694 | 116.729 | 111.979 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Enzyme Technology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 19.467 | 13.992 | 8.528 |
| Current Assets | - | - | - | 10.562 | 36.121 | 64.129 | 58.137 | 89.574 | 115.559 | 117.850 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 691 | 0 |
| Receivables | - | - | - | 10.472 | 35.910 | 63.224 | 56.471 | 89.375 | 114.812 | 94.522 |
| Cash | - | - | - | 90 | 211 | 905 | 1.665 | 198 | 56 | 23.328 |
| Shareholders Funds | - | - | - | 10.246 | 35.815 | 63.832 | 57.244 | 93.743 | 116.778 | 112.027 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 316 | 306 | 297 | 893 | 15.298 | 12.773 | 14.350 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Enzyme Technology S.r.l.